NCAM1 and non-Hodgkin lymphoma: Aggressive tumors. Contrary to nHL most patients presents with symptoms.Pleural effusions 4/5. Ebstein-Barr was positive in 3/5. Those tumors are CD56(+), CD3(+) but CD20(-). Most pts died within 6/12.